Category: Hematology
UNC School of Medicine Physician Scientists Training Program Gives Awards to Cultivate the Careers of Upcoming Physician-Scientists
Medicine, like any other scientific field, cannot progress forward without the hard work of new, cutting-edge researchers. In the Department of Medicine, three physician scientist trainees are working to improve the lives of patients who have inflammatory bowel disease, cancer, and food allergies. In light of their promising, hard work, all three have received support from the UN … Read more
Dr. Stephan Moll Working with NASA to Study Blood Flow, Clot Formation in Zero Gravity
Stephan Moll, MD Are astronauts more likely to develop blood clots during space missions due to zero gravity? That’s the question NASA is trying to answer with help from UNC School of Medicine’s Stephan Moll, MD, professor in the Division of Hematology within the UNC Department of Medicine. A new publication in Vascular Medicine shows the results of an occupational surveillance p … Read more
Dr. Shakira J. Grant selected for PRIDE, hopes to encourage others to find their purpose
Shakira J. Grant, MBBS As an assistant professor in the Divisions of Hematology and Geriatric Medicine, and a board-certified Geriatric-Hematologist, Dr. Shakira J. Grant, MBBS, is no stranger to success, but she has had to overcome many challenges along the way. Now, selected for the 2022 Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) … Read more
epartment of Medicine Grants & Funding: April 1 – April 30, 2022
Division of Hematology Nigel Key, MB, ChB, FRCP has been awarded a 5-year, $2.2M T32 grant from the National Heart, Lung and Blood Institute (NHLBI) Brandi Reeves, MD was awarded a 2-year, $165,000 Hemostasis and Thrombosis Research Society Mentored Research Award to study Hypoxia Inducible Factors in Myeloproliferative Neoplasm-Associated Thrombosis. Rafal Pawlinksi, PhD and Bra … Read more
Department of Medicine Grants & Funding: March 1 – March 31, 2022
Division of Oncology Yara Abdou, MD, received a METAvivor research grant for “Investigating Survivin as a novel target for immunotherapy in Black women with breast cancer.” Jared Weiss, MD, and Barbara Savoldo, MD, received a $1.8M DoD grant to study GD2 CART for lung lancer. Emily Ray, MD, received a 2-year $150,000 Career Development Award from the Lung Cancer Initiative for a … Read more
DVT Awareness Month: Spotlighting Hematology Trial That Serves COVID Patients, BRC’s Thrombosis Related Research
March is Deep-Vein Thrombosis (DVT) Awareness Month, a public health initiative that seeks to aid understanding of a commonly occurring and potentially life-threatening medical condition among the general population. DVT is commonly referred to as a blood clot (thrombus) that forms in one or more veins located deep inside the body. Did you know, almost one in four people don’t kn … Read more
Key awarded a 5-year, $2.2 million T32 grant from NHLBI
Nigel Key, MB, ChB, FRCP Nigel Key, MB, ChB, FRCP has been awarded a 5-year, $2.2 million T32 grant from the National Heart, Lung, and Blood Institute (NHLBI). Now closely aligned with the benign hematology research areas of focus in the Blood Research Center (hemostasis, thrombosis and sickle cell disease), the program will continue to recruit MD and PhD trainees for careers in … Read more
B Cell Function in the Tumor Microenvironment, a Review in Advance, Annual Review of Immunology
Left to right: Jeremy Meier, MD, Benjamin G. Vincent, MD, Jonathan S. Serody, MD, and Stephanie M. Downs-Canner, MD. Jeremy Meier, MD, fellow in the division of hematology, Benjamin G. Vincent, MD, assistant professor in hematology, and Jonathan S. Serody, MD, chief of the division of hematology, are authors of the review “B Cell Function in the Tumor Microenvironment,” soon to b … Read more
Clinical Challenges: Using MRD in Chronic Lymphocytic Leukemia Management
Catherine Coombs, MD For patients with chronic lymphocytic leukemia (CLL), minimal residual disease (MRD) has emerged as a highly sensitive indicator of disease burden during and at the end of treatment, and has correlated with time-to-event outcomes. Use of MRD has shown promise for guiding duration of treatment for CLL patients on time-limited therapy. “MRD measurement is not n … Read more
New Approaches to Hemophilia Treatment: ‘Our Cup Runneth Over’
Alice Ma, MD, FACP In a session titled “Hemophilia Update: Our Cup Runneth Over,” presented at the 2021 annual meeting of the American Society of Hematology (ASH), experts in the treatment of bleeding disorders discussed the optimal use of factor concentrates in people with hemophilia, new and investigational alternatives to factor concentrates, and the promise of long-time contr … Read more
Hematology/Oncology Diversity and Inclusion Initiatives
UNC Lineberger Comprehensive Cancer Center Equity Council Sam Cykert, MD, and Marjory Charlot, MD. Four members of the Department of Medicine are working to bring diversity, equity and inclusion principles into critical areas of UNC Lineberger. “This is a group of 14 faculty, graduate students, and staff–and we’re in the process of identifying patients and community members–com … Read more
Unusual Accident, Blood Clot Diagnosis Leads Leasburg Woman to UNC’s DVT Clinic
Cassi Frank, MMSc,PA-C A Leasburg woman is grateful to be back on her feet after months of surgeries and rehabilitation. While on a cross-country vacation, an unusual accident left her with a huge gash in her leg and swelling that wouldn’t go down. UNC’s hematology specialists determined blood clots were behind the swelling. In a recent CBS-17 news report, Cassi Frank, MMSc, PA- … Read more